If you have previously registered for this event, please login below:

If you have NOT previously registered, please fill in the questions below and hit the "Register" button.

First Name*
Last Name*
Street Address*
Postal Code*
Work Phone*
Would you like to receive our monthly eNewsletter? 
What is your role in evaluating the material used for oncology drug delivery applications and what is your time horizons for new applications?*
What do you know about Eastman Tritan™ copolyester?*
I understand that by registering for this web site, I am submitting the information above to UBM Canon and to Eastman, as sponsor of the webinar. Each company may contact me, including by email, about products and services that it thinks may be of interest to me.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

UBM Privacy Statement
Eastman Privacy Policy

Why Devices are Failing in Oncology Drug Delivery Applications

Available on Demand
Date: January 14, 2016 – January 14, 2017
Duration: 30-minutes

Sponsored by:

About this webinar
One of pharma’s fastest-growing and highest-profile segments is facing a crisis. Some oncology drugs have demonstrated chemical incompatibility with traditional polymers used in delivery devices. Consequently, the ISMP and FDA have issued warnings for health professionals to stop using closed system drug-transfer devices made with polycarbonate or ABS plastics, which can leak, break, or dissolve following exposure to oncology drugs. Recent tests compare the chemical resistance of these polymers with Eastman Tritan™ copolyester.

You will learn:
  • The growing therapeutic and economic importance of oncology drug therapy.
  • The implications of recent ISMP and FDA warning statements for oncology drug delivery.
  • How three engineering polymers withstand exposure to oncology drugs and carrier solvents under stress.

Cynthia Lewis

Market Insight and Strategy Manager, Medical

Steven Givens, Ph.D.

Sr. Polymer Applications Scientist
Eastman Chemical Company